Hatton, C. K., Green, G. A. & Ambrose, P. J. (2014). Performance-enhancing drugs: Understanding the risks. Physical Medicine & Rehabilitation Clinics of North America, 25 (4), 897-913. Zugriff am 05.08.2019 unter https://doi.org/10.1016/j.pmr.2014.06.013
APA-Zitierstil (7. Ausg.)Hatton, C. K., Green, G. A., & Ambrose, P. J. (2014). Performance-enhancing drugs: Understanding the risks. Physical Medicine & Rehabilitation Clinics of North America, 25(4), 897-913.
Chicago-Zitierstil (17. Ausg.)Hatton, C. K., G. A. Green, und P. J. Ambrose. "Performance-enhancing Drugs: Understanding the Risks." Physical Medicine & Rehabilitation Clinics of North America 25, no. 4 (2014): 897-913.
MLA-Zitierstil (9. Ausg.)Hatton, C. K., et al. "Performance-enhancing Drugs: Understanding the Risks." Physical Medicine & Rehabilitation Clinics of North America, vol. 25, no. 4, 2014, pp. 897-913.